147 related articles for article (PubMed ID: 21980168)
1. Urinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration.
Schwaninger AE; Meyer MR; Barnes AJ; Kolbrich-Spargo EA; Gorelick DA; Goodwin RS; Huestis MA; Maurer HH
Clin Chem; 2011 Dec; 57(12):1748-56. PubMed ID: 21980168
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective urinary MDMA (ecstasy) and metabolites excretion kinetics following controlled MDMA administration to humans.
Schwaninger AE; Meyer MR; Barnes AJ; Kolbrich-Spargo EA; Gorelick DA; Goodwin RS; Huestis MA; Maurer HH
Biochem Pharmacol; 2012 Jan; 83(1):131-8. PubMed ID: 21983032
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of the main metabolites of 3,4-methylenedioxymethamphetamine (MDMA), including the sulfate and glucuronide of 4-hydroxy-3-methoxymethamphetamine (HMMA), in humans and rats.
Shima N; Katagi M; Kamata H; Zaitsu K; Kamata T; Nishikawa M; Miki A; Tsuchihashi H; Sakuma T; Nemoto N
Xenobiotica; 2008 Mar; 38(3):314-24. PubMed ID: 18274959
[TBL] [Abstract][Full Text] [Related]
4. Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans.
Abraham TT; Barnes AJ; Lowe RH; Kolbrich Spargo EA; Milman G; Pirnay SO; Gorelick DA; Goodwin RS; Huestis MA
J Anal Toxicol; 2009 Oct; 33(8):439-46. PubMed ID: 19874650
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of LC-HRMS and GC-NICI-MS methods for stereoselective determination of MDMA and its phase I and II metabolites in human urine.
Schwaninger AE; Meyer MR; Huestis MA; Maurer HH
J Mass Spectrom; 2011 Jul; 46(7):603-14. PubMed ID: 21656610
[TBL] [Abstract][Full Text] [Related]
6. Chiral Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine and its Phase I and II Metabolites following Controlled Administration to Humans.
Steuer AE; Schmidhauser C; Schmid Y; Rickli A; Liechti ME; Kraemer T
Drug Metab Dispos; 2015 Dec; 43(12):1864-71. PubMed ID: 26395866
[TBL] [Abstract][Full Text] [Related]
7. Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine.
Shima N; Kamata H; Katagi M; Tsuchihashi H; Sakuma T; Nemoto N
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 857(1):123-9. PubMed ID: 17643356
[TBL] [Abstract][Full Text] [Related]
8. Investigation on the enantioselectivity of the sulfation of the methylenedioxymethamphetamine metabolites 3,4-dihydroxymethamphetamine and 4-hydroxy-3-methoxymethamphetamine using the substrate-depletion approach.
Schwaninger AE; Meyer MR; Maurer HH
Drug Metab Dispos; 2011 Nov; 39(11):1998-2002. PubMed ID: 21795466
[TBL] [Abstract][Full Text] [Related]
9. Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS.
Helmlin HJ; Bracher K; Bourquin D; Vonlanthen D; Brenneisen R
J Anal Toxicol; 1996 Oct; 20(6):432-40. PubMed ID: 8889680
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of an LC-MS/MS method after chiral derivatization for the simultaneous stereoselective determination of methylenedioxy-methamphetamine (MDMA) and its phase I and II metabolites in human blood plasma.
Steuer AE; Schmidhauser C; Liechti ME; Kraemer T
Drug Test Anal; 2015 Jul; 7(7):592-602. PubMed ID: 25371386
[TBL] [Abstract][Full Text] [Related]
11. Sulfation of the 3,4-methylenedioxymethamphetamine (MDMA) metabolites 3,4-dihydroxymethamphetamine (DHMA) and 4-hydroxy-3-methoxymethamphetamine (HMMA) and their capability to inhibit human sulfotransferases.
Schwaninger AE; Meyer MR; Zapp J; Maurer HH
Toxicol Lett; 2011 Apr; 202(2):120-8. PubMed ID: 21295122
[TBL] [Abstract][Full Text] [Related]
12. Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults.
Kolbrich EA; Goodwin RS; Gorelick DA; Hayes RJ; Stein EA; Huestis MA
Ther Drug Monit; 2008 Jun; 30(3):320-32. PubMed ID: 18520604
[TBL] [Abstract][Full Text] [Related]
13. Impact of Cytochrome P450 2D6 Function on the Chiral Blood Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine (MDMA) and Its Phase I and II Metabolites in Humans.
Steuer AE; Schmidhauser C; Tingelhoff EH; Schmid Y; Rickli A; Kraemer T; Liechti ME
PLoS One; 2016; 11(3):e0150955. PubMed ID: 26967321
[TBL] [Abstract][Full Text] [Related]
14. 3,4-Methylenedioxymethamphetamine (MDMA) and metabolites disposition in blood and plasma following controlled oral administration.
Hartman RL; Desrosiers NA; Barnes AJ; Yun K; Scheidweiler KB; Kolbrich-Spargo EA; Gorelick DA; Goodwin RS; Huestis MA
Anal Bioanal Chem; 2014 Jan; 406(2):587-99. PubMed ID: 24232751
[TBL] [Abstract][Full Text] [Related]
15. Screening for illicit drugs in pooled human urine and urinated soil samples and studies on the stability of urinary excretion products of cocaine, MDMA, and MDEA in wastewater by hyphenated mass spectrometry techniques.
Mardal M; Kinyua J; Ramin P; Miserez B; Van Nuijs AL; Covaci A; Meyer MR
Drug Test Anal; 2017 Jan; 9(1):106-114. PubMed ID: 26888521
[TBL] [Abstract][Full Text] [Related]
16. 4-Hydroxy-3-methoxymethamphetamine glucuronide as a phase II metabolite of 3,4-methylenedioxymethamphetamine: enzyme-assisted synthesis and involvement of human hepatic uridine 5'-diphosphate-glucuronosyltransferase 2B15 in the glucuronidation.
Shoda T; Fukuhara K; Goda Y; Okuda H
Chem Pharm Bull (Tokyo); 2009 May; 57(5):472-5. PubMed ID: 19420777
[TBL] [Abstract][Full Text] [Related]
17. Analysis of MDMA and its metabolites in urine and plasma following a neurotoxic dose of MDMA.
Valtier S; Phelix CF; Cody JT
J Anal Toxicol; 2007 Apr; 31(3):138-43. PubMed ID: 17579960
[TBL] [Abstract][Full Text] [Related]
18. Disposition of MDMA and metabolites in human sweat following controlled MDMA administration.
Barnes AJ; De Martinis BS; Gorelick DA; Goodwin RS; Kolbrich EA; Huestis MA
Clin Chem; 2009 Mar; 55(3):454-62. PubMed ID: 19168553
[TBL] [Abstract][Full Text] [Related]
19. Further studies on the role of metabolites in (+/-)-3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity.
Mueller M; Yuan J; Felim A; Neudörffer A; Peters FT; Maurer HH; McCann UD; Largeron M; Ricaurte GA
Drug Metab Dispos; 2009 Oct; 37(10):2079-86. PubMed ID: 19628751
[TBL] [Abstract][Full Text] [Related]
20. Urinary excretion profiles of N-hydroxy-3,4-methylenedioxymethamphetamine in rats.
Tsujikawa K; Mikuma T; Kuwayama K; Miyaguchi H; Kanamori T; Iwata YT; Inoue H
Xenobiotica; 2011 Jul; 41(7):578-84. PubMed ID: 21425955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
